<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38262969</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>23</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Long-term symptoms after SARS-CoV-2 infection in a cohort of hospital employees: duration and predictive factors.</ArticleTitle><Pagination><StartPage>119</StartPage><MedlinePgn>119</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">119</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-023-08710-1</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To evaluate the frequency, duration and patterns of long-term coronavirus disease 2019 (COVID-19) symptoms and to analyse risk factors for long-lasting COVID-19 sequelae among a cohort of hospital employees (HEs).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a survey regarding persistent COVID-19 related symptoms with all HEs from three medical centres in Cologne, Germany, who were tested SARS-CoV-2 PCR positive from March 2020 until May 2021. Duration of symptoms and possible risk factors for protracted COVID-19 course were analysed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 221 included HEs, a number of 104 HEs (47.1%) reported at least one persisting symptom for more than 90 days after initial SARS-CoV-2 detection. Each one cycle higher initial Ct value significantly increased the chances of overcoming symptoms (odds ratio [OR] 1.05; 95% confidence interval (95%CI) 1.01-1.09; p&#x2009;=&#x2009;0.019). The occurrence of breathlessness within the first ten days (OR 7.89; 95%CI 1.87-41.43; p&#x2009;=&#x2009;0.008), an initial Ct value under 30 (OR 3.36; 95%CI 1.22-9.94; p&#x2009;=&#x2009;0.022) as well as the occurrence of anosmia or ageusia within the first ten days (OR 3.01; 95%CI 1.10-8.84; p&#x2009;=&#x2009;0.037) showed a statistically significant association with increased odds of illness duration over 90 days.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">About half of the HEs suffered from long lasting symptoms over 90 days after almost entirely mild acute COVID-19. Predictive factors could possibly be used for early treatment to prevent development of long-term symptoms after COVID-19 in future.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gruber</LastName><ForeName>Rosalie</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Hygiene, Cologne Merheim Medical Centre, University Hospital of Witten/Herdecke, Ostmerheimer Stra&#xdf;e 200, 51109, K&#xf6;ln, Germany. GruberR@kliniken-koeln.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Hygiene and Environmental Medicine, Department of Human Medicine, Faculty of Health, Witten/Herdecke University, Alfred-Herrhausen-Stra&#xdf;e 50, 58448, Witten, Germany. GruberR@kliniken-koeln.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montilva Ludewig</LastName><ForeName>Mar&#xed;a Ver&#xf3;nica</ForeName><Initials>MV</Initials><AffiliationInfo><Affiliation>Institute of Hygiene, Cologne Merheim Medical Centre, University Hospital of Witten/Herdecke, Ostmerheimer Stra&#xdf;e 200, 51109, K&#xf6;ln, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Hygiene and Environmental Medicine, Department of Human Medicine, Faculty of Health, Witten/Herdecke University, Alfred-Herrhausen-Stra&#xdf;e 50, 58448, Witten, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>We&#xdf;els</LastName><ForeName>Christina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Hygiene, Cologne Merheim Medical Centre, University Hospital of Witten/Herdecke, Ostmerheimer Stra&#xdf;e 200, 51109, K&#xf6;ln, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Hygiene and Environmental Medicine, Department of Human Medicine, Faculty of Health, Witten/Herdecke University, Alfred-Herrhausen-Stra&#xdf;e 50, 58448, Witten, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schlang</LastName><ForeName>Gerlinde</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Occupational Health Service, Cologne Municipal Hospitals, Neufelder Stra&#xdf;e 34, 51067, K&#xf6;ln, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jedhoff</LastName><ForeName>Svenja</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Statistical Consulting and Analysis, Centre for Higher Education, TU Dortmund University, Vogelpothsweg 78, 44227, Dortmund, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herbrandt</LastName><ForeName>Swetlana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Statistical Consulting and Analysis, Centre for Higher Education, TU Dortmund University, Vogelpothsweg 78, 44227, Dortmund, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mattner</LastName><ForeName>Frauke</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute of Hygiene, Cologne Merheim Medical Centre, University Hospital of Witten/Herdecke, Ostmerheimer Stra&#xdf;e 200, 51109, K&#xf6;ln, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Hygiene and Environmental Medicine, Department of Human Medicine, Faculty of Health, Witten/Herdecke University, Alfred-Herrhausen-Stra&#xdf;e 50, 58448, Witten, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010564" MajorTopicYN="N">Personnel, Hospital</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000370" MajorTopicYN="Y">Ageusia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Healthcare worker</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Post COVID syndrome</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>24</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>23</Day><Hour>23</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38262969</ArticleId><ArticleId IdType="pmc">PMC10807182</ArticleId><ArticleId IdType="doi">10.1186/s12879-023-08710-1</ArticleId><ArticleId IdType="pii">10.1186/s12879-023-08710-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lai CC, Shih TP, Ko WC, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020;55(3):105924. doi: 10.1016/j.ijantimicag.2020.105924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2020.105924</ArticleId><ArticleId IdType="pmc">PMC7127800</ArticleId><ArticleId IdType="pubmed">32081636</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Guan X, Wu P, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020;382(13):1199&#x2013;207. doi: 10.1056/NEJMoa2001316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001316</ArticleId><ArticleId IdType="pmc">PMC7121484</ArticleId><ArticleId IdType="pubmed">31995857</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandjour A, Long COVID. Costs for the German economy and health care and pension system. BMC Health Serv Res. 2023;23(1):641. doi: 10.1186/s12913-023-09601-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-023-09601-6</ArticleId><ArticleId IdType="pmc">PMC10266873</ArticleId><ArticleId IdType="pubmed">37316880</ArticleId></ArticleIdList></Reference><Reference><Citation>Robert Koch-Institut RKI. COVID-19 Dashboard. 2021. https://experience.arcgis.com/experience/478220a4c454480e823b17327b2bf1d4 (accessed 17.02.2022).</Citation></Reference><Reference><Citation>WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis. 2020;20(8):e192&#x2013;e7. doi: 10.1016/S1473-3099(20)30483-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30483-7</ArticleId><ArticleId IdType="pmc">PMC7292605</ArticleId><ArticleId IdType="pubmed">32539990</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;32. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T, Hittle M, Goodman SN. Assessment of the frequency and Variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw open. 2021;4(5):e2111417. doi: 10.1001/jamanetworkopen.2021.11417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D, Sun A, Ssentongo AE, et al. Short-term and long-term rates of Postacute Sequelae of SARS-CoV-2 Infection: a systematic review. JAMA Netw open. 2021;4(10):e2128568. doi: 10.1001/jamanetworkopen.2021.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Vedel S&#xf8;rensen AI, Spiliopoulos L, Bager P, et al. Post-acute symptoms, new onset diagnoses and health problems 6 to 12 months after SARS-CoV-2 Infection: a nationwide questionnaire study in the adult Danish population. medRxiv. 2022. 2022.02.27.22271328.</Citation></Reference><Reference><Citation>Augustin M, Schommers P, Stecher M, et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Europe. 2021;6:100122. doi: 10.1016/j.lanepe.2021.100122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence (NICE)., Scottish Intercollegiate Guidelines Network (SIGN) and Royal College of General Practitioners (RCGP) (2022), COVID-19 rapid guideline: managing the longterm effects of COVID-19. Version 1.14 published on 01.03.2022 (accessed 10.08.2023).</Citation></Reference><Reference><Citation>World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus. 2021. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.</Citation></Reference><Reference><Citation>Wanney J, L&#xfc;sebrink J, Sp&#xf6;lgen G, et al. Direct comparison of Altona-SARS-CoV-2 dual target RT-qPCR assay with commercial LAMP assay using throat washes in health care staff testing. J Clin Virol Plus. 2022;2(3):100088. doi: 10.1016/j.jcvp.2022.100088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcvp.2022.100088</ArticleId><ArticleId IdType="pmc">PMC9159961</ArticleId><ArticleId IdType="pubmed">35669098</ArticleId></ArticleIdList></Reference><Reference><Citation>Malecki M, Luesebrink J, Wendel AF, et al. Analysis of external quality assessment samples revealed crucial performance differences between commercial RT-PCR assays for SARS-CoV-2 detection when taking extraction methods and real-time-PCR instruments into account. J Virol Methods. 2021;295:114202. doi: 10.1016/j.jviromet.2021.114202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2021.114202</ArticleId><ArticleId IdType="pmc">PMC8169234</ArticleId><ArticleId IdType="pubmed">34087340</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones R, Davis A, Stanley B, et al. Risk predictors and Symptom features of Long COVID within a Broad Primary Care Patient Population including both tested and untested patients. Pragmatic and Observational Research. 2021;12:93&#x2013;104. doi: 10.2147/POR.S316186.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/POR.S316186</ArticleId><ArticleId IdType="pmc">PMC8366779</ArticleId><ArticleId IdType="pubmed">34408531</ArticleId></ArticleIdList></Reference><Reference><Citation>Westerlind E, Palstam A, Sunnerhagen KS, Persson HC. Patterns and predictors of sick leave after Covid-19 and long Covid in a national Swedish cohort. BMC Public Health. 2021;21(1):1023. doi: 10.1186/s12889-021-11013-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-021-11013-2</ArticleId><ArticleId IdType="pmc">PMC8164957</ArticleId><ArticleId IdType="pubmed">34059034</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team. R: A Language and Environment for Statistical Computing. 2021. https://www.R-project.org/.</Citation></Reference><Reference><Citation>Epskamp S, Cramer AOJ, Waldorp LJ, Schmittmann VD, Borsboom D. Qgraph: network visualizations of relationships in Psychometric Data. J Stat Soft. 2012;4:1&#x2013;18.</Citation></Reference><Reference><Citation>Therneau TM. A Package for Survival Analysis in R. 2021. https://CRAN.R-project.org/package=survival.</Citation></Reference><Reference><Citation>Cox DR. Regression models and life tables. J R Stat Soc. 1972;34:187&#x2013;202.</Citation></Reference><Reference><Citation>Agresti A. Categorical Data Analysis. 2. New York: John Wiley &amp; Sons; 2002.</Citation></Reference><Reference><Citation>Robert Koch-Institut. COVID-19: Entlassungskriterien aus der Isolierung. 2023. https://edoc.rki.de/bitstream/handle/176904/6867/20_0316_Entlasskriterien_A3_V11.pdf?sequence=1&amp;isAllowed=y: (accessed 10.08.2023).</Citation></Reference><Reference><Citation>Robert Koch-Institut. Hinweise zur Testung von Patientinnen und Patienten auf SARS-CoV-2. 2023. https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Vorl_Testung_nCoV.html (accessed 10.08.2023).</Citation></Reference><Reference><Citation>Carvalho-Schneider C, Laurent E, Lemaignen A, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infection: Official Publication Eur Soc Clin Microbiol Infect Dis. 2020;27(2):258&#x2013;63. doi: 10.1016/j.cmi.2020.09.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.052</ArticleId><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Roessler M, Tesch F, Batram M et al. Post COVID-19 in children, adolescents, and adults: results of a matched cohort study including more than 150,000 individuals with COVID-19. medRxiv 2021: 2021.10.21.21265133.</Citation></Reference><Reference><Citation>Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol. 2022;23(2):194&#x2013;202. doi: 10.1038/s41590-021-01104-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Zazhytska M, Kodra A, Hoagland DA et al. Non-cell-autonomous disruption of nuclear architecture as a potential cause of COVID-19-induced anosmia. Cell 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8808699</ArticleId><ArticleId IdType="pubmed">35180380</ArticleId></ArticleIdList></Reference><Reference><Citation>Etter MM, Martins A, Kulsvehagen T. L, Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and signs of neurodegeneration: a prospective cross-sectional study. medRxiv 2022: 2022.02.18.22271039.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9645766</ArticleId><ArticleId IdType="pubmed">36351919</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran AV, Jayadevan R, Sashidharan S, Long COVID. An overview. Diabetes &amp; Metabolic Syndrome. 2021;15(3):869&#x2013;75. doi: 10.1016/j.dsx.2021.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis. 2021;53(10):737&#x2013;54. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Karimzadeh S, Bhopal R, Nguyen Tien H. Review of infective dose, routes of transmission and outcome of COVID-19 caused by the SARS-COV-2: comparison with other respiratory viruses. Epidemiol Infect. 2021;149:e96. doi: 10.1017/S0950268821000790. Erratum in: Epidemiol Infect. 2021;149:e116. PMID: 33849679; PMCID: PMC8082124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8082124</ArticleId><ArticleId IdType="pubmed">33849679</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Damme W, Dahake R, van de Pas R et al. COVID-19: does the infectious inoculum dose-response relationship contribute to understanding heterogeneity in Disease severity and transmission dynamics? Medical hypotheses, Volume 146, 2021,110431.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7686757</ArticleId><ArticleId IdType="pubmed">33288314</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen K, Ren S, Heath K, et al. Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 Infection: retrospective cohort study. BMJ. 2022;376:e068414. doi: 10.1136/bmj-2021-068414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-068414</ArticleId><ArticleId IdType="pmc">PMC8828141</ArticleId><ArticleId IdType="pubmed">35140117</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022;28(8):1706&#x2013;14. doi: 10.1038/s41591-022-01909-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Choi T, Al-Aly Z. Association of Treatment with Nirmatrelvir and the risk of Post-COVID-19 Condition. JAMA Intern Med. 2023;183(6):554&#x2013;64. doi: 10.1001/jamainternmed.2023.0743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0743</ArticleId><ArticleId IdType="pmc">PMC10037200</ArticleId><ArticleId IdType="pubmed">36951829</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuodi P, Gorelik Y, Zayyad H et al. Association between vaccination status and reported incidence of post-acute COVID-19 symptoms in Israel: a cross-sectional study of patients tested between March 2020 and November 2021. medRxiv 2022: 2022.01.05.22268800.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>